Mitico specializes in advanced carbon capture solutions, utilizing a patented granulated metal carbonate sorption technology developed at Caltech. This innovative approach effectively captures over 95% of carbon dioxide emissions from post-combustion sources, such as gas-fired power plants, boilers, and waste-to-energy facilities. By providing carbon capture, utilization, and storage (CCUS) as a service, Mitico enables clients to significantly reduce their carbon emissions at a lower cost compared to conventional methods. The company's technology aims to facilitate mass mitigation of carbon emissions, making it an essential partner for industries seeking to address environmental challenges and transition towards more sustainable practices.
MIIST Therapeutics is a pulmonary drug delivery system and digital platform that enhances the science of inhaled drugs. In order to reduce the excessive quantity of death and sickness brought on by tobacco use, MIIST is actively developing technology that will be used as a smoking cessation therapy.
Aralez Bio specializes in the sustainable production of noncanonical amino acids (ncAAs), which are also known as unusual or unnatural amino acids. The company has developed a novel enzymatic method that allows for the synthesis of over 100 ncAAs with perfect enantiopurity in a single step, using water as the sole byproduct. This innovative approach provides clients with access to essential amino acids required for advancements in pharmaceuticals, agriculture, and functional materials, thereby supporting various sectors in their product development efforts.
Persperity Health is pioneering the future of women's health with cutting-edge, non-invasive technology that tracks female hormones in real time.
Esperto Medical is a medical device company based in Irvine, California, focused on developing advanced wearable diagnostic tools for both hospital and remote patient monitoring. The company utilizes a proprietary technology called resonance sonomanometry, which employs acoustic stimulation to measure blood pressure continuously and noninvasively, eliminating the need for calibration. By offering round-the-clock monitoring capabilities, Esperto Medical aims to enhance patient care and accessibility, allowing individuals to track their vital signs conveniently from home or within clinical settings.
Calicat is a clean-energy company developing a proprietary electrocatalyst discovery process for electrolyser. The company electrocatalyst discovery is an unprecedented, proprietary, end-to-end ultrahigh throughput AI and data-driven process focused on the discovery of new catalysts for the generation of clean hydrogen and fuel cell power production. The process prepares, characterizes, and quantifies the catalytic activity of millions of compositions per month and then closes the loop with big data analysis and AI to refine/guide the search.
Curry it is a food manufacturing company that offers ready-to-cook curries, pastes, and mixes for vegetarian and non-vegetarian recipes.
Holoclara is an immunotherapy company focused on developing treatments for autoimmune disorders using nematode-derived molecules. The company aims to provide relief to individuals suffering from these conditions by offering a range of services that include the delivery of therapeutics derived from worm species. These molecules are identified for their potent therapeutic properties and are being developed into safe, orally available treatments. Holoclara’s initiatives are designed to enable patients to lead healthier lives while addressing the challenges posed by autoimmune disorders.
StrokeDx develops rapid and portable devices to transform how strokes are diagnosed. The company's full-time software engineering team works on novel algorithms using machine learning and AI approaches to fuel the diagnostic accuracy and imaging capabilities of the StrokeDx sensor.
Catena Biosciences is a biotechnology company focused on advancing protein conjugation technology to develop novel therapeutics for autoimmune disorders, oncology, and vaccine development. The company specializes in the efficient and selective attachment of proteins using natural amino acids, specifically tyrosine and cysteine. This innovative approach allows researchers to create biologic structures more rapidly than traditional methods, enhancing the potential for medical research and treatment options in various disease areas. Catena Biosciences aims to contribute significantly to the field of biomedicine through its cutting-edge technology and applications.
Tierra Biosciences is a synthetic biology company focused on advancing the discovery of bioengineered products through innovative technologies. Founded in 2015 and headquartered in San Francisco, California, the company specializes in cell-free technologies that facilitate the production of complex molecules that traditional laboratory cells find challenging to generate. Its Next Generation Expression platform integrates automation, computation, and high-throughput cell-free expression to enable rapid, experimentally validated data collection, surpassing the limitations of simulation-based methods. By combining cell-free protein production with artificial intelligence, Tierra Biosciences aims to streamline protein manufacturing, making it as accessible as e-commerce. The company was formerly known as Synvitrobio, Inc., before rebranding in September 2018.
Captura is a company focused on direct ocean carbon capture, developing technology to efficiently extract carbon dioxide from ocean water. Its innovative system leverages the natural carbon removal capabilities of the ocean to capture atmospheric CO2 on a large scale and at a low cost. This approach not only addresses the urgent need for carbon sequestration but also aligns with the increasing demand for carbon credits in the market. By utilizing renewable electricity and ocean water, Captura's technology operates sustainably, producing no harmful by-products and contributing significantly to efforts against climate change.
Mitico specializes in advanced carbon capture solutions, utilizing a patented granulated metal carbonate sorption technology developed at Caltech. This innovative approach effectively captures over 95% of carbon dioxide emissions from post-combustion sources, such as gas-fired power plants, boilers, and waste-to-energy facilities. By providing carbon capture, utilization, and storage (CCUS) as a service, Mitico enables clients to significantly reduce their carbon emissions at a lower cost compared to conventional methods. The company's technology aims to facilitate mass mitigation of carbon emissions, making it an essential partner for industries seeking to address environmental challenges and transition towards more sustainable practices.
Continuum Space Systems develops a Unified Mission Management platform aimed at enhancing the planning and execution of space missions. This software as a service (SaaS) tool allows companies to efficiently manage all stages of a mission, from ideation through design to operational execution. By providing advanced technological solutions, the platform enables organizations to conduct space missions that are safer, less risky, and more cost-effective.
Hydrosat is a climate technology company based in Washington, D.C., founded in 2017. It specializes in utilizing thermal infrared satellite imagery to deliver geospatial analytics that help monitor and manage water resources effectively. By measuring water stress in agriculture, Hydrosat aims to improve food security, public safety, and environmental sustainability. Its services enable various sectors, including agriculture, financial services, and government, to transform satellite data into actionable insights, facilitating better decision-making and resource management.
Switch Therapeutics is a biotechnology company established in 2020 and located in San Francisco, California. The company focuses on developing innovative RNA interference (RNAi) therapies aimed at transforming the treatment of various diseases, particularly those affecting the central nervous system and other systemic conditions with significant unmet medical needs. By integrating nucleic acid nanotechnology with RNAi science, Switch Therapeutics creates biomarker-gated genetic medicines designed to activate RNA molecules and therapies specifically in targeted cells. This targeted approach aims to enhance the effectiveness of treatments for central nervous system diseases, providing healthcare providers with advanced therapeutic options.
Wild Microbes is a microbial platform focused on producing sustainable chemicals, ingredients, and materials through the application of synthetic biology. By developing new microbial strains, the company enhances the efficiency and cost-effectiveness of producing a wide range of products, including plastics and proteins. Their expertise in cultivating and engineering microbes allows various industries to adopt more sustainable practices, promoting environmental responsibility while meeting market demands. Wild Microbes aims to accelerate the transition to sustainable alternatives by leveraging innovative microbial technologies.
Membrion, Inc., founded in 2016 and based in Seattle, Washington, specializes in the manufacturing and commercialization of advanced membranes that filter molecules, including ions, under a variety of conditions such as heat, acidity, and biological sensitivity. Originating as a spin-out from the University of Washington, Membrion has received funding from multiple organizations, including the National Science Foundation and private investors, which has facilitated the transition from research to commercial production. The company's innovative ion exchange membrane technology is designed for applications in flow batteries, water purification, fuel cells, and pharmaceuticals, offering clients membranes that feature a longer lifespan and reduced costs.
Captura is a company focused on direct ocean carbon capture, developing technology to efficiently extract carbon dioxide from ocean water. Its innovative system leverages the natural carbon removal capabilities of the ocean to capture atmospheric CO2 on a large scale and at a low cost. This approach not only addresses the urgent need for carbon sequestration but also aligns with the increasing demand for carbon credits in the market. By utilizing renewable electricity and ocean water, Captura's technology operates sustainably, producing no harmful by-products and contributing significantly to efforts against climate change.
Calicat is a clean-energy company developing a proprietary electrocatalyst discovery process for electrolyser. The company electrocatalyst discovery is an unprecedented, proprietary, end-to-end ultrahigh throughput AI and data-driven process focused on the discovery of new catalysts for the generation of clean hydrogen and fuel cell power production. The process prepares, characterizes, and quantifies the catalytic activity of millions of compositions per month and then closes the loop with big data analysis and AI to refine/guide the search.
Comprehensive health care solutions to bring, nurse, assistant, meds, basic diagnostics to the home along with paneled doctors for virtual consultations and home visits.
Hydrosat is a climate technology company based in Washington, D.C., founded in 2017. It specializes in utilizing thermal infrared satellite imagery to deliver geospatial analytics that help monitor and manage water resources effectively. By measuring water stress in agriculture, Hydrosat aims to improve food security, public safety, and environmental sustainability. Its services enable various sectors, including agriculture, financial services, and government, to transform satellite data into actionable insights, facilitating better decision-making and resource management.
Hydrosat is a climate technology company based in Washington, D.C., founded in 2017. It specializes in utilizing thermal infrared satellite imagery to deliver geospatial analytics that help monitor and manage water resources effectively. By measuring water stress in agriculture, Hydrosat aims to improve food security, public safety, and environmental sustainability. Its services enable various sectors, including agriculture, financial services, and government, to transform satellite data into actionable insights, facilitating better decision-making and resource management.
Appia Bio is a biotechnology company dedicated to the research and development of allogeneic cell therapies that can be readily available for patients. The company focuses on creating engineered cell therapies for various medical conditions using its innovative ACUA technology platform. This platform utilizes the biology of lymphocyte development along with chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering to produce CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes derived from hematopoietic stem cells. By maturing and scaling healthy stem cells into these therapies, Appia Bio aims to provide safe and targeted cancer treatments, thereby enhancing accessibility to off-the-shelf cell therapies for physicians and patients alike.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.